Talk:MEAI

Revision as of 16:58, 22 November 2018 by >Kenan (Kenan moved page MEAI to Talk:MEAI without leaving a redirect)
MEAI
[[ {{{SkeletalImageFile}}} | frameless | center | {{{SkeletalImageWidth}}} ]]
[[ {{{3DImageFile}}} | frameless | center | {{{3DImageWidth}}} ]]
Chemical Nomenclature
Common names MEAI, Chaperon
Substitutive name 5-Methoxy-2-indanamine
Systematic name {{{NameSystematic}}}
Class Membership
Psychoactive class Entactogen
Chemical class Aminoindane
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Duration
Total 4 - 6 hours
Onset 15 - 120 minutes
Peak 2 - 2.5 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.


5-Methoxy-2-indanamine (commonly known as MEAI or Chaperon). 5-methoxy-2-aminoindane (MEAI) was 'created' in December 2014 by a recreational drug chemist who goes by Dr. Z, who filed a patent application on the drug in November 2014. It was later donated to Professor David Nutt's charitable research group DrugScience.

Return to "MEAI" page.